oral chemotherapy for stage 3 breast cancer
Tài liệu Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study pdf
Ngày tải lên :
15/02/2014, 04:20
... 3. 61 0.56 0.42–0. 73
Yes 23 3 10.11 1. 43 0.14 0. 03 0.47
5-y predicted breast cancer risk, %
ഛ2.00 35 13 5.54 2.06 0 .37 0.18–0.72
2.01 3. 00 42 29 5.18 3. 51 0.68 0.41–1.11
3. 01–5.00 43 27 5.88 3. 88 ... 0 .39 –0.66
Age, y
ഛ49 68 38 6.70 3. 77 0.56 0 .37 –0.85
50–59 50 25 6.28 3. 10 0.49 0.29–0.81
ജ60 57 26 7 .33 3. 33 0.45 0.27–0.74
History of LCIS
No 157 81 6.41 3. 30 0.51 0 .39 –0.68
Yes 18 8 12.99 5.69 ... 0 .39 –1.09
ജ5.01 55 20 13. 28 4.52 0 .34 0.19–0.58
No. of first-degree relatives with breast cancer
0 38 17 6.45 2.97 0.46 0.24–0.84
1 90 46 6.00 3. 03 0.51 0 .35 –0. 73
2 37 20 8.68 4.75 0.55 0 .30 –0.97
ജ3...
- 18
- 645
- 0
Guidelines for management of breast cancer ppt
Ngày tải lên :
28/03/2014, 23:20
... treatment
of early stage invasive breast cancer including surgery, adjuvant therapy for node-
negative and node-positive breast cancer, primary chemotherapy in locally-advanced
breast cancer, the definitions ...
the breast. Chapter 6 presents guidelines for the pathological handling of breast cancer
excision specimens and Chapter 7 outlines radiotherapy guidelines for breast cancer.
42 Guidelines for ... of early breast cancer. Journal of Clinical Oncology, 20 03, 21(17) :33 57–
33 65.
Goodman RL et al. The relationship between radiation fields and regional lymph nodes
in carcinoma of the breast. ...
- 57
- 423
- 0
Báo cáo hóa học: "Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival" ppt
Ngày tải lên :
18/06/2014, 16:20
... (1.1, 3. 6) 0. 03 39.9 2.1 (1.2, 3. 6) 0.008
>1.75 90 25.0 3. 5 (1.9, 6.4) < 0.001 14.2 3. 6 (2.1, 6.1) < 0.001
Age
≤ 55 years 78 82.1 1.0 82.1 1.0
>55 years 30 1 40.8 3. 3 (1.5, 7.2) 0.0 03 ... (20.6) 23. 4 23. 7 11.1 0. 039
>55 years 30 1 (79.4) 76.6 76 .3 88.9
Size of tumour
≤ 2 cm 272 (71.8) 78.7 69.6 64.4 0.047
>2 cm 107 (28.2) 21 .3 30.4 35 .6
Grade of tumour
1 & 2 33 8 (89.2) ... and
computed architectural complexity in breast cancer specimens. Hum
Pathol 2008, 39 :740-746.
23. Baish JW, Jain KJ: Fractals and cancer. Cancer Res 2000, 60 :36 83- 3688.
24. Cross SS: Fractals in pathology....
- 10
- 490
- 0
Báo cáo y học: "PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers"
Ngày tải lên :
31/10/2012, 16:57
... in the treatment of breast cancer.
Key words: PARP inhibitors, BRCA1, breast cancer, therapeutic treatment, AG1 436 1
1. Introduction
Breast cancer is the leading cause of cancer
incidence and ... changes [21, 22, 38 ,
40- 43] . This may account for the differential resistance to PARP inhibition observed between BRCA mutant
cancer cells and pre-cancerous cells [36 ].
Figure 3. Effect of a ... Bioessays 2000; 22: 728 -37 .
12. Deng CX, and Wang RH. Roles of BRCA1 in DNA damage
repair: a link between development and cancer. Hum Mol
Genet 20 03; 12: R1 13- 23.
13. Deng CX. Roles of BRCA1...
- 7
- 415
- 0
Tài liệu Screening for Breast Cancer: Systematic Evidence Review Update for the U. S. Preventive Services Task Force doc
Ngày tải lên :
14/02/2014, 21:20
... from breast
cancer was equal in both groups ( 135 / 132 ,979 and 131 / 133 ,085, respectively; RR 1. 03; 95% CI
0.81-1 .31 ). Women who died of breast cancer were identified from a registry kept by the ... for women age 39 -49 years 13
Results for women age 70-74 years 13
Comparisons with meta-analyses for women age 50-59 years and 60-69 years 13
Key Question 1b. Does CBE screening decrease breast ... individual
risks for breast cancer 60-85% and may be identified in 5-10% of all breast cancer cases.
28
Personal history of noninvasive breast cancer or previous abnormal breast biopsy containing...
- 95
- 1K
- 0
Tài liệu SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY ppt
Ngày tải lên :
15/02/2014, 05:20
... treatment for breast cancer in Norway: comparative
analysis of cancer registry data. BMJ 2011 ;34 3:d4692.
20. NHS cancer screening programmes. BASO Breast Audit 1999/2000.
www.cancerscreening.nhs.uk/breastscreen/publications.html ... analysis of WHO mortality database. BMJ 2011 ;34 3:d4411.
13. Bleyer A. US breast cancer mortality is consistent with European data.
BMJ 2011 ;34 3:d5 630 .
3
Summary
When we first published ... background for our information in this
leaflet below.
SCREENING FOR BREAST CANCER
WITH MAMMOGRAPHY
What are the benefits and harms of attending a
screening programme for breast cancer? ...
- 15
- 528
- 3
Mammography and Beyond: Developing Technologies for the Early Detection of Breast Cancer pptx
Ngày tải lên :
05/03/2014, 12:20
... mainstays for early detection of
breast cancer. Screening for early cancer detection has been credited for
part of the recent reduction in breast cancer mortality, which had been
stagnant for 40 ... and the
rationale for the early detection of breast cancer is similar.
Fifty years ago, there was no established method for the detection of
breast cancer at an early stage or for screening of ... translational research in breast cancer.
2-year period. Program in imaging technology dedicated to
research and development for early detection
and diagnosis of breast cancer.
Breast Cancer Research Foundation;...
- 311
- 1.3K
- 0
BREAST CANCER - TREATMENT GUIDELINES FOR PATIENTS potx
Ngày tải lên :
06/03/2014, 01:20
...
When chemotherapy is given after surgery
for early stage breast cancer, it is called
adjuvant chemotherapy. Sometimes chemo-
therapy is given before surgery. This is called
neoadjuvant chemotherapy. ...
A breast cancer s stage is one of the most
important factors that may predict prognosis
(outlook for cure versus the chance of cancer
coming back or spreading to other organs).
A cancer s stage, ... are likely to
lead to cuts.
For more information on lymphedema, call
the American Cancer Society at 1-800-ACS- 234 5
and ask for Lymphedema: What Every Women
With Breast Cancer Should Know.
Radiation...
- 92
- 411
- 0
Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-based Chemotherapy and Radiation pptx
Ngày tải lên :
06/03/2014, 01:20
...
XRT
31 /60 (52%)
33 /62 ( 53% )
not reported
p=0.92
Morris, 1999 (3)
(RTOG 90-01)
43
XRT + CP/5FU
XRT (pelvis + para-aortic lymph nodes)
134 /1 93 (69%)
90/1 93 (47%)
0.48
(0 .35 to 0.66) ...
FIGO
-
228 (62%)
10 (3% )
118 (32 %)
12 (3% )
Bulky stage IB cervical cancer
Keys, 1999
(6)
(GOG-1 23)
37 4 /36 9 /36 9
299 squamous cell (81%)
27 adenosquamous
23 adenocarcinoma
20 other ...
110 (28%)
8 (2%)
Singh, 20 03
(3u)
96/84/84
squamous cell (100%)
clinical
53 ( 63% )
3 (4%)
28 (33 %)
* no follow-up data for 2 patients; †no follow-up data for 6 patients
PG 4-5 IN...
- 31
- 386
- 0
European guidelines for quality assurance in breast cancer screening and diagnosis pot
Ngày tải lên :
15/03/2014, 00:20
... Background and aims 33 7
8.2 Definitions 33 7
8 .3 Data reporting and audit systems 33 8
8 .3. 1 The European Screening Evaluation Database (SEED) 33 9
8 .3. 2 Audit system on Quality of breast cancer diagnosis ... points 35 3
9.12 References 35 4
1100 Guidelines for training 35 5
10.10 Introduction 35 7
10.20 General requirements 35 7
10 .30 Epidemiologist 35 8
10.40 Physicist 35 8
10.50 Breast Radiographer 35 9
10.60 ... 35 9
10.60 Breast Radiologist 36 0
10.70 Breast Pathologist 36 1
10.80 Breast Surgeon 36 2
10.90 Breast Care Nurse 36 3
10.10 Medical Oncologist / Radiotherapist 36 3
10.11 Bibliography 36 4
1111 Certification...
- 432
- 460
- 0